Moderna closes in on release of COVID-19 vaccine data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
Mizuho Securities Reiterates Buy Rating on Pfizer (PFE)
November 12, 2020 8:22 AM ESTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $44.00 price target on Pfizer (NYSE: PFE) following the company's COVID-19 vaccine data released on Monday. The COVID-19 data was eagerly anticipated by investors for obvious reasons.
The company has already secured commitments from... More



